Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
155
-
Total 13F shares, excl. options
-
57M
-
Shares change
-
-3.71M
-
Total reported value, excl. options
-
$119M
-
Value change
-
-$1.73M
-
Put/Call ratio
-
0.74
-
Number of buys
-
102
-
Number of sells
-
-63
-
Price
-
$2.09
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q2 2025
203 filings reported holding HUMA - Humacyte, Inc. - COM as of Q2 2025.
Humacyte, Inc. - COM (HUMA) has 155 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57M shares
.
Largest 10 shareholders include BlackRock, Inc. (9.95M shares), VANGUARD GROUP INC (7M shares), STATE STREET CORP (4.39M shares), CenterBook Partners LP (3.43M shares), GEODE CAPITAL MANAGEMENT, LLC (2.95M shares), MARSHALL WACE, LLP (2.64M shares), MILLENNIUM MANAGEMENT LLC (2.55M shares), UBS Group AG (2.45M shares), Woodline Partners LP (2M shares), and TWO SIGMA INVESTMENTS, LP (1.54M shares).
This table shows the top 155 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.